Intelligence / Healthtech / De Novo Grants
ApprovalsLIVEUpdated 19 Nov 2026
De Novo Grants
Novel medical devices FDA granted through De Novo in the last 24 months: first of their kind, each creating a new device type.
Sources: openFDA device 510(k) (De Novo) · Rebuilt weekly · Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code.
Grants
58
in the 24 months to 2026-11-19
Added in 30 days
2
to 19 Nov 2026
Top specialty
Neurology
10 · 17% of the list
Country covered
8
distinct values
Snapshot · 19 Nov 2026
Explore all 58 Growth
Cumulative over time
58
Dec 2024Nov 2026
Signals
What the register says this week, and why it matters if you sell into it.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
- A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
GrantedCompanyDeviceSpecialtyCountry
21 Aug 2026Matap Ii, LLCAventura, FLAvuluxNeurologyUnited States8 May 2026Neurovalens LimitedPortglenone, United KingdomModius SperoNeurologyUnited Kingdom3 Apr 2026Automated Imaging Diagnostics, LLCGainesville, FLneuropacsNeurologyUnited States14 Nov 2025Fusmobile, Inc.Alpharetta, GANeurolyser XR (NXR100)NeurologyUnited States6 Oct 2025Painchek Limited (Ltd.)Sydney, AustraliaPainChek (PainChek Adult)NeurologyAustralia20 Aug 2025Quantalx Neuroscience, Ltd.Kfar-Saba, IsraelDelphi-MD SystemNeurologyIsrael17 Jun 2025Tissium SAParis, FranceCOAPTIUM Connect with TISSIUM LIGHTNeurologyFrance17 Apr 2025Epi-Minder Pty, Ltd.Melbourne, AustraliaMinder SystemNeurologyAustralia11 Apr 2025Click Therapeutics, Inc.New York, NYCT-132NeurologyUnited States17 Jan 2025MyoceneLiège, BelgiumMyoceneNeurologyBelgium// How AOS uses this